On Dec 4, Yong Tai inked a heads of agreement (HoA) with China-based Shenzhen Kangtai Biological Products Co Ltd (SZKT) for the development and exclusive commercialisation of the latter’s inactivated Covid-19 vaccine in Malaysia. Under the deal, Yong Tai will supply 100 million doses of the vaccine over a five-year period.
--- 亮點 1 : 疫情的需求, 與專業機構的合作, 以及擁有至少5年的獨家代理權.
A definitive agreement is expected to be signed between the two parties before Christmas, according to Boo. Meanwhile, Yong Tai has appointed Kinsel Sdn Bhd to conduct the clinical study of the Covid-19 vaccine in Malaysia.
--- 亮點 2 : 相信很快會發布相關 agreement.
When the Phase I and II results are made available by the end of this month or early January, the Phase III protocol will be submitted to the Ministry of Health (MoH) and National Pharmaceutical Regulatory Agency for approval, says Boo. “Then only can we work with Clinical Research Malaysia (CRM) to get the volunteers and carry out the trials. We have had a few meetings with CRM. The MoH and CRM has welcomed us to carry out the test.”
--- 亮點 4 : Phase III 臨床試驗即將在馬來西亞實施.
The financial commitment for the vaccine venture will be funded by internally generated funds as well as Yong Tai’s recently proposed private placement, which aims to raise up to RM92.02 million.
--- 亮點 5 : RM92.02 million 資源的投入, 代表集團對此新商機的認真投入, 而不是喊口號.
After a kitchen-sinking exercise in FY2019, the company recorded a higher net profit of RM437,000 in the first quarter ended Sept 30, 2020 (1QFY2021), against RM174,000 in the previous corresponding quarter. The improved performance was also driven by higher contribution from its property development business. It had bank borrowings of RM209.6 million as at end-September, resulting in a net debt position of RM202.1 million and a gearing ratio of 0.39 times.
--- 亮點 6 : 經營管理得到良好的改善.
Over the next two years, Yong Tai will be supported by unbilled sales of RM397 million (as at end-September), attributable to its ongoing property developments, namely The Apple, Amber Cove and The Dawn in Melaka and Impression U-Thant in Kuala Lumpur. Their take-up rates range from 50% to 97%.
--- 亮點 7 : 房地產業務的未來儲備經濟來源.
In our planning, it is slated to have shows (Encore Melaka theatre) every weekend from February 2021,” says Boo.
--- 亮點 8 : Encore Melaka theatre 即將重啟, 透過場次的有效管理, 增加營收或達致該事業體的損益平衡, 有助於整體營收.